SOURCE: Asantae Holdings International Inc.

November 01, 2011 15:22 ET

Asantae Holdings International Inc. Announces Appointment of Dan Lundell to Its Board of Directors

VANCOUVER, BC--(Marketwire - Nov 1, 2011) - Asantae Holdings International Inc. (TSX-V: JVA) is pleased to announce the appointment of Dan Lundell to its board of directors and as its Chief Operations Officer. Mr. Lundell also serves as the Chief Financial Officer and Corporate Secretary of Asantae.

Mr. Lundell is a founding shareholder of Asantae and, in recent months, has provided significant executive leadership. Asantae's Chairman, the Honourable John Reynolds, is excited about Mr. Lundell's increased responsibilities. "Under Dan's guidance, Asantae has crafted a path to growth with RealW8. We are confident that Dan will continue to add leadership and value to all Asantae's stakeholders."

Asantae also announces that it has granted 730,000 incentive stock options to certain employees of the company, including 250,000 options granted to an officer and director of the company. The options are exercisable at a price of $0.16 per share for a period of five years from the date of grant.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About Asantae

Asantae Holdings International Inc. (TSX-V: JVA) is a producer and marketer of innovative nutritional products through direct and network marketing channels. The ingredients in Asantae's products have been shown to reduce chronic low-grade inflammation and oxidative stress which, according to scientific and medical research, are the underlying conditions for most modern epidemic diseases (diabetes, heart disease, obesity, stroke, etc.).

Contact Information

  • For further information respecting the Company please contact:

    Daniel Lundell
    COO/CFO
    10153 E Hampton Ave, Ste. 101
    Mesa, Arizona, 85209 USA
    Phone: (480) 278-8712 and Fax: (480) 383-6147